Development of Highly Potent Anticancer Complexes against Drug Resistance and Drug Mechanism Study
Participate in the synthesis and/or biological evaluation of anticancer agents using mouse models, including toxicity study, xenograft test, pharmacokinetic and pharmacodynamic studies. Industrial experience in pharmaceutical company is preferred.
A Master’s/Bachelor’s degree in Chemistry/Biology/Pharmacology or other related fields with no more than a total of 6 years of service at the University. Extensive experience in drug discovery including synthetic, inorganic chemistry or animal studies is required.
Salary offered will be highly competitive, commensurate with qualifications and experience. Fringe benefits include leave, medical and dental consultations at the campus clinic.
Further information on the posts and the University is available at http://www.cityu.edu.hk, or from the Human Resources Office, City University of Hong Kong, Tat Chee Avenue, Kowloon Tong, Hong Kong [Email : hrojob@cityu.edu.hk/Fax : 2788 1154 or 3442 0311].
To apply, please submit an online application. The closing date is 31 March 2023. Applications will receive full consideration and only shortlisted applicants will be contacted. The University’s privacy policy is available on the homepage.
City University of Hong Kong is an equal opportunity employer. We are committed to the principle of diversity. Personal data provided by applicants will be used for recruitment and other employment-related purposes.
Worldwide recognition ranking #70 (QS 2024), and #4 among top 50 universities under age 50 (QS 2021); #1 in the World’s Most International Universities (THE 2024); #1 in Automation & Control/Electrical & Electronic Engineering/Materials Science & Engineering/Metallurgical Engineering/Nanoscience & Nanotechnology and #2 in Telecommunication Engineering in Hong Kong (GRAS 2023); and #39 Business School in the World and #5 in Asia (UT Dallas 2019 to 2023)